Lymphomatoid papulosis while on efalizumab.
Leo
Angela M
AM
Ermolovich
Tanya
T
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D003875:Drug Eruptions / Q000473:pathology*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D017731:Lymphomatoid Papulosis / Q000139:chemically induced* / Q000473:pathology*; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; C472181:efalizumab